REFERENCES
- Bryant , J. , Day , R. ( 1995 ). Incorporating toxicity considerations into the design of two-stage phase II clinical trials . Biometrics 51 ( 4 ): 1372 – 1383 .
- Champagne , M. A. , Fu , C. H. , Chang , M. , Cooley , L. , Heerema , H. , Wood , C. , French , M. E. , Smith , F. O. , Bernstein , M. L. ( 2006 ). Imatinib in children with newly diagnosed chronic phase chronic myelogenous leukemia (CP CML): AAML0123 COG Study . Blood 108 ( 11 ): 607a, abstract 2140 .
- Conaway , M. , Petroni , G. ( 1995 ). Bivariate sequential designs for phase II trials . Biometrics 51 ( 2 ): 656 – 664 .
- Conaway , M. , Petroni , G. ( 1996 ). Designs for phase II trials allowing for a trade-off between response and toxicity . Biometrics 52 ( 4 ): 1375 – 1386 .
- Dempster , A. P. , Laird , N. M. , Robin , D. B. ( 1977 ). Maximum likelihood estimation from incomplete data via the EM algorithm (with discussion) . J. R. Stat. Soc. B 39 : 1 – 38 .
- Efron , B. ( 1967 ). The two sample problem with censored data . Proc. Fifth Berkeley Symposium on Mathematical Statistics and Probability 4 : 831 – 853 .
- Lehmann , E. L. ( 1991 ). Theory of Point Estimation . Belmont , CA : Wadsworth .
- Little , R. J. A. , Robin , D. B. ( 2002 ). Statistical Analysis with Missing Data . New York : John Wiley & Sons .
- Sargent , D. J. , Sloan , J. A. , Cha , S. S. ( 1999 ). Sample size and design considerations for Phase II clinical trials with correlated observations . Control. Clin. Trials 19 : 242 – 252 .